European Respiratory Journal (ERJ) - Archive
 |
|
Published in the English language, the ERJ features:
- cutting edge clinical and experimental work in the field of respiratory medicine
- original articles
- series
- editorials
- correspondence
- short reports and case studies
All of which pertain the highest quality from professionals on a worldwide scale. The ERJ is the most highly regarded, peer reviewed, Respiratory Journal in Europe. |
| October (Issue 4 Volume 36) |  |
| Allied respiratory professionals
Cooper B.G., Troosters T., Burge G., Field D., Hrafnkelsdottir S.S., Pitta F., Lloyd J.K., Steenbuggen I.
Eur Respir J 2010; 36: 701-703 |  |  | | | | | | | | | | | The continuing challenge of air pollution
Brunekreef B.
Eur Respir J 2010; 36: 704-705 | | | | | | | | | | | | | Tainted eponyms in medicine: the “Clara” cell joins the list
Woywodt A., Lefrak S., Matteson E.
Eur Respir J 2010; 36: 706-708 | | | | | | | | | | | | | Rho kinase inhibitors for pulmonary hypertension: waiting for clinical evidence
Pacaud P., Loirand G.
Eur Respir J 2010; 36: 709-711 | | | | | | | | | | | | | The paradox in pneumococcal serotypes: highly invasive does not mean highly lethal
Pletz M.W., Welte T., Klugman K.P.
Eur Respir J 2010; 36: 712-713 | | | | | | | | | | | | | The European Respiratory Journal targets tuberculosis
Lange C., Yew W.W., Migliori G.B., Raviglione M.
Eur Respir J 2010; 36: 714-715 | | | | | | | | | | | | | Lung development, lung growth and the future of respiratory medicine
Ranganathan S.
Eur Respir J 2010; 36: 716-717 | | | | | | | | | | | | | The light at the end of the tunnel: is COPD prevalence changing?
Celli B.R.
Eur Respir J 2010; 36: 718-719 | | | | | | | | | | | | | What makes large epidemiological studies comparable?
Cerveri I., De Marco R.
Eur Respir J 2010; 36: 720-721 | | | | | | | | | | | | | The Clara cell: a “Third Reich eponym”?
Winkelmann A., Noack T.
Eur Respir J 2010; 36: 722-727 | | |  | | | | | | | | | | Factors influencing duration of exposure with symptoms and costs of occupational asthma
Miedinger D., Malo J-L., Ghezzo H., L'Archevêque J., Zunzunegui M-V.
Eur Respir J 2010; 36: 728-734 | | | | | | | | | | | | | Application of a prediction model for work-related sensitisation in bakery workers
Meijer E., Suarthana E., Rooijackers J., Grobbee D.E., Jacobs J.H., Meijster T., de Monchy J.G.R., van Otterloo E., van Rooy F.G.B.G.J., Spithoven J.J.G., Zaat V.A.C., Heederik D.J.J.
Eur Respir J 2010; 36: 735-742 | | | | | | | | | | | | | The occupational contribution to severe exacerbation of asthma
Henneberger P.K., Mirabelli M.C., Kogevinas M., Antó J.M., Plana E., Dahlman- Höglund A., Jarvis D.L., Kromhout H., Lillienberg L., Norbäck D., Olivieri M., Radon K., Torén K., Urrutia I., Villani S., Zock J.P.
Eur Respir J 2010; 36: 743-750 | | | | | | | | | | | | | Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia
Malo de Molina R., Mortensen E.M., Restrepo M.I., Copeland L.A., Pugh M.J.V., Anzueto A.
Eur Respir J 2010; 36: 751-757 | | | | | | | | | | | | | Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007
Soriano J.B., Ancochea J., Miravitlles M., García-Río F., Duran-Tauleria E., Muñoz L., Jiménez-Ruiz C.A., Masa J.F., Viejo J.L., Villasante C., Fernández-Fau L., Sánchez G., Sobradillo-Peña V.
Eur Respir J 2010; 36: 758-765 | | | | | | | | | | | | | No increase in the prevalence of COPD in two decades
Vasankari T.M., Impivaara O., Heliövaara M., Heistaro S., Liippo K., Puukka P., Saarelainen S., Kanervisto M., Jousilahti P.
Eur Respir J 2010; 36: 766-773 | | | | | | | | | | | | | Impact of dietary shift to higher-antioxidant foods in COPD: a randomised trial
Keranis E., Makris D., Rodopoulou P., Martinou H., Papamakarios G., Daniil Z., Zintzaras E., Gourgoulianis K.I.
Eur Respir J 2010; 36: 774-780 | | | | | | | | | | | | | Plasmacytoid dendritic cells in pulmonary lymphoid follicles of patients with COPD
Van Pottelberge G.R., Bracke K.R., Van den Broeck S., Reinartz S.M., van Drunen C.M., Wouters E.F., Verleden G.M., Vermassen F.E., Joos G.F., Brusselle G.G.
Eur Respir J 2010; 36: 781-791 | | | | | | | | | | | | | Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study
Ghofrani H.A., Hoeper M.M., Halank M., Meyer F.J., Staehler G., Behr J., Ewert R., Weimann G., Grimminger F.
Eur Respir J 2010; 36: 792-799 | | | | | | | | | | | | | Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil
Mouchaers K.T.B., Schalij I., de Boer M.A., Postmus P.E., van Hinsbergh V.W.M., van Nieuw Amerongen G.P., Vonk Noordegraaf A., van der Laarse W.J.
Eur Respir J 2010; 36: 800-807 | | | | | | | | | | | | | Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension
Dahal B.K., Kosanovic D., Pamarthi P.K., Sydykov A., Lai Y-J., Kast R., Schirok H., Stasch J-P., Ghofrani H.A., Weissmann N., Grimminger F., Seeger W., Schermuly R.T.
Eur Respir J 2010; 36: 808-818 | | | | | | | | | | | | | Elevated brain natriuretic peptide predicts mortality in interstitial lung disease
Corte T.J., Wort S.J., Gatzoulis M.A., Engel R., Giannakoulas G., Macdonald P.M., Wells A.U.
Eur Respir J 2010; 36: 819-825 | | | | | | | | | | | | | The impact of a delay in intensive care unit admission for community-acquired pneumonia
Phua J., Ngerng W.J., Lim T.K.
Eur Respir J 2010; 36: 826-833 | | | | | | | | | | | | | Influence of genetic ancestry on the risk of obstructive sleep apnoea syndrome
Guindalini C., Colugnati F.A.B., Pellegrino R., Santos-Silva R., Bittencourt L.R.A., Tufik S.
Eur Respir J 2010; 36: 834-841 | | | | | | | | | | | | | Is tidal expiratory flow limitation predictive of sleep-related disorders in the elderly?
Guillot M., Costes F., Sforza E., Maudoux D., Bertoletti L., Barthélémy J.C., Roche F.
Eur Respir J 2010; 36: 842-848 | | | | | | | | | | | | | CME | Pregnancy and fetal outcomes of symptoms of sleep-disordered breathing
Bourjeily G., Raker C.A., Chalhoub M., Miller M.A.
Eur Respir J 2010; 36: 849-855 | | | | | | | | | | | | | Serotype-specific pneumococcal disease may be influenced by mannose-binding lectin deficiency
Vallès X., Roca A., Lozano F., Morais L., Suárez B., Casals F., Mandomando I., Sigaúque B., Nhalungo D., Esquinas C., Quintó L., Alonso P.L., Torres A.
Eur Respir J 2010; 36: 856-863 | | | | | | | | | | | | | Characteristics of hospitalised patients with 2009 H1N1 influenza in Chile
Riquelme R., Riquelme M., Rioseco M.L., Inzunza C., Gomez Y., Contreras C., Riquelme J., Peyrani P., Wiemken T., Ramirez J.
Eur Respir J 2010; 36: 864-869 | | | | | | | | | | | | | Predicting outcomes and drug resistance with standardised treatment of active tuberculosis
Oxlade O., Schwartzman K., Pai M., Heymann J., Benedetti A., Royce S., Menzies D.
Eur Respir J 2010; 36: 870-877 | | | | | | | | | | | | | Ongoing tuberculosis transmission to children in Greenland
Soborg B., Koch A., Thomsen V.Ø. , Ladefoged K., Andersson M., Wohlfahrt J., Melbye M., Andersen A.B.
Eur Respir J 2010; 36: 878-884 | | | | | | | | | | | | | Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer
Kumar S., Guleria R., Singh V., Bharti A.C., Mohan A., Das B.C.
Eur Respir J 2010; 36: 885-892 | | | | | | | | | | | | | Systemic sclerosis and bilateral lung transplantation: a single centre experience
Saggar R., Khanna D., Furst D.E., Belperio J.A., Park G.S., Weigt S.S., Kubak B., Ardehali A., Derhovanessian A., Clements P.J., Shapiro S., Hunter C., Gregson A., Fishbein M.C., Lynch III J.P., Ross D.J., Saggar R.
Eur Respir J 2010; 36: 893-900 | | | | | | | | | | | | | An experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated piglets
Martínez-Olondris P., Sibila O., C. Agustí, Rigol M., Soy D., Esquinas C., Piñer R., Luque N., Guerrero L., Quera M.Á., Marco F., de la Bellacasa J.P., Ramirez J., Torres A.
Eur Respir J 2010; 36: 901-906 | | | | | | | | | | | | | Overexpression of transforming growth factor-β1 in fetal monkey lung results in prenatal pulmonary fibrosis
Tarantal A.F., Chen H., Shi T.T., Lu C-H., Fang A.B., Buckley S., Kolb M., Gauldie J., Warburton D., Shi W.
Eur Respir J 2010; 36: 907-914 | | | | | | | | | | | | | Current data on predictive markers for anti-angiogenic therapy in thoracic tumours
Reinmuth N., Thomas M., Meister M., Schnabel P.A., Kreuter M.
Eur Respir J 2010; 36: 915-924 | | | | | | | | | | | | | Tuberculosis contact investigation in low prevalence countries: a European consensus
Erkens C.G.M., Kamphorst M., Abubakar I., Bothamley G.H., Chemtob D., Haas W., Migliori G.B., Rieder H.L., Zellweger J-P., Lange C.
Eur Respir J 2010; 36: 925-949 | | | | | | | | | | | | | Epigenetic mechanisms and the relationship to childhood asthma
Kabesch M., Michel S., Tost J.
Eur Respir J 2010; 36: 950-961 | | | | | | | | | | | | | Occupational asthma to solder wire containing an adipic acid flux
Moore V.C., Burge P.S.
Eur Respir J 2010; 36: 962-963 | | | | | | | | | | | | | Response to salbutamol in patients with mild asthma treated with nadolol
Hanania N.A., Mannava B., Franklin A.E., Lipworth B.J., Williamson P.A., Garner W.J., Dickey B.F., Bond R.A.
Eur Respir J 2010; 36: 963-965 | | | | | | | | | | | | | Endobronchial metallic clips to guide high-dose external-beam radiotherapy in radio-occult lung cancer
Malfait T., van Eijkeren M., van Meerbeeck J.P., Tournoy K.G.
Eur Respir J 2010; 36: 965-967 | | | | | | | | | | | | | Iloprost-induced thrombocytopenia: a case proven by rechallenge
Taegtmeyer A.B., Zettler C., Siegemund M., Tsakiris D.A., Rätz Bravo A.E., Pargger H., Kraehenbuehl S., Haschke M.
Eur Respir J 2010; 36: 967-969 | | | | | | | | | | | | | Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia
To K.K.W., Chan K-H., Fung Y-F., Yuen K-Y., Ho P-L.
Eur Respir J 2010; 36: 969-971 | | | | | | | | | | | | | Assessment of bronchoreversibility in severe emphysema
Hansen J.E.
Eur Respir J 2010; 36: 972 | | | | | | | | | | | | | From the authors:
Han M.K., Martinez F.J.
Eur Respir J 2010; 36: 973 | | | | | | | | | | | | | Inhaled corticosteroids: a controversial add-on treatment in COPD
Puhan M.A.
Eur Respir J 2010; 36: 973-974 | | | | | | | | | | | | | From the authors:
Singh S., Loke Y.K.
Eur Respir J 2010; 36: 974 | | | | | | | | | | | | | From the authors
Sin D.D., Man S.F.P.
Eur Respir J 2010; 36: 974-975 | | | | | | | | | | | |
|
|
WHAT YOU CAN FIND HERE  |
 |
Full text journal article |
 |
PDF journal article |
 |
Journal article abstract |
|
|